Unraveling molecular signatures of immunostimulatory adjuvants in the female genital tract through systems biology
| Autor: | Ali M. Harandi, Madelene Lindqvist, Intawat Nookaew, Jens Nielsen, Ingrid Brinkenberg, Emma Samuelson, Karolina Thörn |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2011 |
| Předmět: |
CpG Oligodeoxynucleotide
medicine.medical_treatment Systems biology lcsh:Medicine Biology Transcriptome Mice Immune system Adjuvants Immunologic Vaccine Development medicine Animals lcsh:Science Biological Phenomena Inflammation Vaccines Multidisciplinary Systems Biology Gene Expression Profiling Vaccination lcsh:R Immunity Computational Biology Mice Inbred C57BL Administration Intravaginal medicine.anatomical_structure Gene Expression Regulation Immunization Vagina Immunology Medicine Clinical Immunology Female lcsh:Q Adjuvant Research Article Signal Transduction |
| Zdroj: | PLoS ONE, Vol 6, Iss 6, p e20448 (2011) PLoS ONE |
| ISSN: | 1932-6203 |
| Popis: | Sexually transmitted infections (STIs) unequivocally represent a major public health concern in both industrialized and developing countries. Previous efforts to develop vaccines for systemic immunization against a large number of STIs in humans have been unsuccessful. There is currently a drive to develop mucosal vaccines and adjuvants for delivery through the genital tract to confer protective immunity against STIs. Identification of molecular signatures that can be used as biomarkers for adjuvant potency can inform rational development of potent mucosal adjuvants. Here, we used systems biology to study global gene expression and signature molecules and pathways in the mouse vagina after treatment with two classes of experimental adjuvants. The Toll-like receptor 9 agonist CpG ODN and the invariant natural killer T cell agonist alpha-galactosylceramide, which we previously identified as equally potent vaginal adjuvants, were selected for this study. Our integrated analysis of genome-wide transcriptome data determined which signature pathways, processes and networks are shared by or otherwise exclusive to these 2 classes of experimental vaginal adjuvants in the mouse vagina. To our knowledge, this is the first integrated genome-wide transcriptome analysis of the effects of immunomodulatory adjuvants on the female genital tract of a mammal. These results could inform rational development of effective mucosal adjuvants for vaccination against STIs. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|